A strong temperature excursion response, continuous logging, exception monitoring, on-site rescue, same-day reshipment, protects the product physically. It does not answer the question a QA director actually needs answered: is the product still viable enough to release, or does it need to be quarantined or destroyed? Our breakdown of what a real excursion response looks like covers detection and recovery in detail. This piece picks up where that one stops: the disposition decision that determines what happens to the product after it is back in range.
Mean kinetic temperature, or MKT, is a single calculated temperature that represents the cumulative thermal stress a product experienced across a variable temperature profile. It is not a simple average. Because degradation rates increase non-linearly with temperature under the Arrhenius model, a shipment that spent a short time at a high temperature can carry more thermal stress than one held slightly warm for much longer, even if their arithmetic average temperature is identical. MKT accounts for that by weighting higher temperatures more heavily, using an activation energy value tied to the product’s own stability data. The result is a single number that can be compared directly against the range the product was validated to tolerate.
A disposition decision after a temperature excursion rests on three ideas working together, and a logistics partner only controls one of them.
A product’s stability data does not just define a target storage range; it also defines how much cumulative time and temperature deviation the product can absorb before quality is compromised. That cumulative allowance is often called a stability budget, and the logistics-stage version of it is the allowable time out of storage: how much of that budget a given shipment has left after an excursion. A shipment can exceed its labeled range and still fall inside its stability budget, or stay close to range for too long and exceed it. Duration and magnitude both count.
An MKT calculation only means something once it is compared against the product’s approved stability data. A result that falls inside the validated range supports releasing the product as-is. A result that exceeds it does not automatically mean the product is unusable, but it does mean the decision moves out of logistics and into the hands of whoever owns that stability data.
The manufacturer’s pharmaceutical quality assurance team, not the logistics provider, owns the stability data that defines what an excursion actually costs a given product. A logistics partner’s job is to produce a clean, complete temperature record and MKT calculation fast enough for that team to make the call before the shipment’s usable window closes. Incomplete or late data does not just slow the decision. It can force a QA team into the conservative default: quarantine or reject, even when the product might have been fine.
Disposition comes down to three outcomes. Accept means the excursion stayed within the stability budget and the product releases without restriction. Quarantine holds the product while QA gathers more information, additional stability testing, a formal risk assessment, before a final call. Reject means the excursion exceeded what the stability data supports, and the product cannot be released for patient use. The decision has to be documented with the same rigor as the excursion itself: what the MKT calculation showed, what stability data it was measured against, who made the call, and when.
A disposition decision is only as fast as the data behind it.
Within temperature controlled logistics, good distribution practice treats excursion disposition as part of the quality system, not a separate process bolted on afterward. Eagle Life Science documents chain of custody and deviation records as part of a broader pharmaceutical logistics compliance program, so cold chain compliance and the temperature data behind a disposition decision are generated as the shipment moves rather than reconstructed afterward. Every partner in Eagle’s vetted network operates under a signed quality agreement, which keeps chain of custody documentation consistent from pickup through delivery instead of fragmenting at each handoff, exactly the point where disposition data usually goes missing.
Every disposition decision needs a paper trail an auditor can follow without asking a follow-up question: the temperature log, the MKT calculation, the stability data it was compared against, and the disposition outcome, all tied to a single record. If the temperature excursion points to a process failure, a lane that consistently runs hot, a handoff with no cold storage, it needs a documented corrective and preventive action, or CAPA, not just a one-time fix. Depending on the product and the market, a disposition decision may also trigger a formal notification to the relevant regulatory authority, which is easier to meet on time when the underlying data was captured correctly the first time.
The fastest disposition decision is the one a shipment never needs. Validating a cold chain lane before it ships catches the packaging and routing gaps that cause most excursions before product ever moves, and understanding the common failure points in cold chain shipments narrows where monitoring needs to focus. Eagle’s facility sits less than two miles from Boston Logan International Airport, which keeps dwell time, the window where temperature drift is hardest to catch, as short as possible. When a temperature excursion does happen, that same proximity means the temperature record, MKT calculation, and disposition-ready documentation reach QA faster, while the shipment still has a stability budget worth acting on.
What is mean kinetic temperature?
A single calculated temperature that represents the cumulative thermal stress a product experienced across a variable temperature profile, weighted for how degradation actually responds to heat rather than a simple average.
What happens after a temperature excursion is detected?
The shipment is recovered and requalified, then its temperature record is compared against the product’s stability data through an MKT calculation to determine whether the product can be accepted, must be quarantined, or should be rejected.
How is MKT different from an average temperature?
A simple average treats every degree the same. MKT weights higher temperatures more heavily because degradation accelerates faster than temperature rises, so a brief spike can carry more risk than a longer, milder deviation.
What is a stability budget?
The cumulative amount of time and temperature deviation a product’s stability data shows it can absorb before quality is considered compromised, whether that time is spent during manufacturing, storage, or transport.
Who decides whether a product is accepted, quarantined, or rejected after an excursion?
The manufacturer’s quality assurance team, using the stability data it owns, the MKT calculation, and the documented temperature record from the logistics provider.
Does every temperature excursion require regulatory notification?
Not automatically. It depends on the product, the market, and whether the excursion exceeds what the stability data supports, but the decision needs documentation ready to support that determination either way.
What documentation does a disposition decision require?
The temperature log, the MKT calculation, the stability data it was measured against, the disposition outcome, and, if a process failure caused the excursion, a documented CAPA.
A temperature excursion is not the failure. A disposition decision made without complete data is. Eagle Life Science builds the temperature record, MKT calculation, and GDP-documented chain of custody into every shipment as it happens, so QA has what it needs the moment a call has to be made. Bring Eagle your product’s stability parameters and see how fast a disposition-ready record comes together.
https://www.eagle-freight.com/wp-content/uploads/2026/09/Good-Distribution-Practice-GDP-A-Compliance-Guide-for-Pharmaceutical-Logistics.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2026-09-11 15:35:202026-09-11 15:37:11Good Distribution Practice (GDP): A Compliance Guide for Pharmaceutical Logistics https://www.eagle-freight.com/wp-content/uploads/2026/06/Laboratory-Sample-Logistics-in-Boston-The-Chain-of-Custody-Gap-Most-Organizations-Miss-at-Logan.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2026-06-16 10:27:042026-06-16 10:28:35Laboratory Sample Logistics in Boston: The Chain-of-Custody Gap Most Organizations Miss at Logan https://www.eagle-freight.com/wp-content/uploads/2026/06/Pharmaceutical-Last-Mile-Delivery-In-a-Pull-Model-Supply-Chain-Its-the-Only-Leg-That-Cant-Fail.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2026-06-16 10:12:002026-06-16 10:12:03Pharmaceutical Last Mile Delivery: In a Pull-Model Supply Chain, It’s the Only Leg That Can’t Fail https://www.eagle-freight.com/wp-content/uploads/2026/06/The-process-of-loading-medical-ampoules-for-vaccines-onto-a-conveyor_.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2026-06-16 08:35:242026-06-16 08:35:26Why CDMOs Are Debating Freight Mode When Pharmaceutical Importer of Record Liability Is the Real Risk https://www.eagle-freight.com/wp-content/uploads/2026/02/Dry-Ice-Replenishment-In-Bond.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2026-02-27 15:46:322026-04-24 11:12:49How Dry Ice Shipping in Bond Protects Pharmaceutical Shipments https://www.eagle-freight.com/wp-content/uploads/2025/12/How-Cold-Chain-Logistics-Ensures-Pharmaceutical-Safety.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2025-12-22 10:01:342026-04-24 16:56:17How Cold Chain Pharmaceutical Logistics Ensures Product Integrity & Patient Safety https://www.eagle-freight.com/wp-content/uploads/2025/12/How-Cold-Chain-Logistics-Safeguards-Pharmaceutical-Integrity.jpg 1250 2000 Abstrakt Marketing /wp-content/uploads/2025/08/EagleHeader-1.png Abstrakt Marketing2025-12-18 12:29:442026-04-24 11:12:50How to Evaluate a Cold Chain Logistics Provider for Pharmaceutical Shipments